NASDAQ, GERN - Geron Corp
Geron is developing first-in-class biopharmaceuticals for the treatment of
cancer and chronic degenerative diseases, including spinal cord injury, heart
failure and diabetes. We are advancing telomerase targeted therapies, including
an anti-cancer drug and a cancer vaccine, through multiple clinical trials. We
are also the world leader in the development of human embryonic stem cell-based
therapeutics, with our spinal cord injury treatment anticipated to be the first
such product to enter clinical development.
We were incorporated in 1990 under the laws of Delaware. Our principal
executive offices are located at 230 Constitution Drive, Menlo Park, California
94025. Our telephone number is (650) 473-7700. ...
Read SEC Filing on NASDAQ.com »